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Circadian clocks in pancreatic islets participate in the regulation of glucose homeostasis. Herewe examined the role
of these timekeepers in β-cell regeneration after themassive ablation of β cells by doxycycline-induced expression of
diphtheria toxin A (DTA) in Insulin-rtTA/TET-DTAmice. Since we crossed reporter genes expressing α- and β-cell-
specific fluorescent proteins into these mice, we could follow the fate of α- and β cells separately. As expected, DTA
induction resulted in an acute hyperglycemia, which was accompanied by dramatic changes in gene expression in
residual β cells. In contrast, only temporal alterations of gene expression were observed in α cells. Interestingly,
β cells entered S phase preferentially during the nocturnal activity phase, indicating that the diurnal rhythm also
plays a role in the orchestration of β-cell regeneration. Indeed, in arrhythmic Bmal1-deficient mice, which lack
circadian clocks, no compensatory β-cell proliferation was observed, and the β-cell ablation led to aggravated
hyperglycemia, hyperglucagonemia, and fatal diabetes.
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The circadian system allows organisms to synchronize
physiology and behavior to the changes of geophysical
time repeatable every 24 h. In mammals, the clock net-
work is organized in a hierarchical manner. It comprises
a master pacemaker, located in the paired suprachiasmat-
ic nuclei (SCN) of the hypothalamus, that orchestrates the
timing of peripheral oscillators situated in all organs on a
daily basis (Dibner 2020). The molecular clocks rely on
two coupled auto-regulatory transcriptional–translational
negative feedback loops (TTFLs). In the primaryTTFL, the
transcriptional activators BMAL1 and CLOCK form a het-
erodimer that activates transcription of the genes encod-
ing the negative limb members PER1–3 and CRY1–2
(Cox and Takahashi 2019; Sinturel et al. 2020). CRY and
PER proteins form complexes that translocate to the nu-
cleus and inhibit the action of BMAL1 and CLOCK on
their own transcription (Aryal et al. 2017). In the second-
ary TTFL, members of the nuclear orphan receptor fami-
lies ROR and REV-ERB drive the circadian transcription
of the positive limb members BMAL1 and CLOCK (Dib-
ner et al. 2010).
A coupling between the circadian oscillator and the cell
division cycle has been observed in cultured fibroblasts
(Nagoshi et al. 2004) and in tissues with high proliferative
activity, such as oral mucosa, skin (Bjarnason et al. 2001),
and intestinal epithelium (Karpowicz et al. 2013; Stokes
et al. 2017). Indeed, core clock components were demon-
strated to directly drive the expression of key cell cycle
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genes comprisingWee1, Cyclins, andMyc1 (Matsuo et al.
2003), and to gate cytokinesis to a specific timewithin the
circadian cycle (Nagoshi et al. 2004; Bieler et al. 2014).
Both the cell division cycle and the circadian clock under-
go significant changes uponmalignant transformation, al-
though no clear causal links between the two processes
are known (Mannic et al. 2013; Gaucher et al. 2018).
The importance of temporal coordination of cell prolif-
eration has emerged in the context of reparative regenera-
tion in tissues that bear intrinsic regenerative capacity,
such as liver, intestine, and skeletal muscle (Matsuo
et al. 2003; Karpowicz et al. 2013; Chatterjee et al. 2015;
Bellet et al. 2016; Stokes et al. 2017). Rodent studies sug-
gest that β cells have a limited potential for regeneration
via replication of existing β cells (Dor et al. 2004; Nir
et al. 2007; Stolovich-Rain et al. 2012; Klochendler et al.
2016) or trans-differentiation from adjacent ductal epithe-
lial cells (Xu et al. 2008), α cells (Thorel et al. 2010; Chak-
ravarthy et al. 2017), and δ cells (Chera et al. 2014).
Unlike fast regenerating tissues including liver, the regen-
eration of β cells is a long-lasting process that takes a few
weeks and even months in mice (Nir et al. 2007; Cheng
et al. 2017). Core clock componentsmay play a role in reg-
ulating β-cell division. Indeed,mice lacking at least one al-
lele of Bmal1 in β cells fail to increase β-cell mass in
response to diet-induced obesity (Rakshit et al. 2016),
and siRNA-mediated down-regulation of RORγ attenuat-
ed glucose-driven induction of cell cycle-related genes
and the proliferation rate in INS-1E cell line (Schmidt
et al. 2016). Unraveling mechanisms of regulation of β-
cell regeneration is of a fundamental clinical importance
in the search of new therapeutic approaches for manage-
ment of diabetes mellitus.
Molecularclocksoperative inpancreatic islets (Pulimeno
et al. 2013) play a critical role in islet cell physiology and in
regulating glucose homeostasis (Marcheva et al. 2010; Pet-
renkoet al. 2017b; Sinturel et al. 2020). Indeed,miceharbor-
ing whole-body or tissue-specific null alleles for essential
core clockcomponentsdevelophyperglycemia,hypoinsuli-
nemia and glucose intolerance (Marcheva et al. 2010; Dyar
et al. 2014; Perelis et al. 2015;Rakshit et al. 2016).Although
perturbation of the islet clocks emerges as a part of type 2
diabetes (T2D) pathogenesis in humans (Petrenko et al.
2020), it remains unclear whether alterations of the mo-
lecular clockwork precede development of T2D or stem
from the disease progression. Thus, understanding the
functional link between changes of the molecular clock-
work, islet dysfunction and β-cell regeneration potential
is an important challenge. In this work we studied the di-
urnal regulation of β-cell proliferation and profiled the cir-
cadian transcriptomes of α and β cells following massive
β-cell ablation in the Insulin-rtTA/TET-DTA mouse mod-
el in the presence or absence of functional clocks.
Results
β-Cell regeneration follows a diurnal pattern
In order to study the impact of the circadian system on
β-cell dysfunction and regeneration, we used Insulin-
rtTA/TET-DTA transgenic mice, in which the ablation
of ∼80% of β cells can be induced in a controlled manner
(Nir et al. 2007). This mouse strain was crossed with tri-
ple-reporter mice (Petrenko et al. 2017b) that expressed
fluorescent protein reporters specific for α cells (ProGluca-
gon [Gcg]-Venus) and β cells (rat Insulin2 promoter [RIP]-
Cherry), along with the ubiquitously expressed circadian
bioluminescence reporter Period2::Luciferase (Per2::Luc)
(Supplemental Fig. S1A). The resulting mouse model en-
compassing five transgenes permitted to conduct parallel
analyses of the transcriptional landscape separately in re-
sidual β cells and neighboring α cells following massive β-
cell ablation. Administration of doxycycline (DOX) to the
drinking water during 7–10 d induced amassive β-cell loss
in Insulin-rtTA/TET-DTA mice (Supplemental Fig. S1B),
resulting in acute hyperglycaemia sustained for at least
14 d (Supplemental Fig. S1C), consistent with previous
publications (Nir et al. 2007).
We first assessed whether entry into the S phase of the
cell cycle of remnant β cells exhibited a diurnal profile.
This was done by injecting 5-bromo-2′-deoxyuridine
(BrdU), a marker of DNA replication during S phase, 2 h
prior to sacrificing the animals at 6 time points with 4-h
intervals across 24 h. In accordance to previously pub-
lished data (Nir et al. 2007), we observed overall increased
BrdU incorporation in the nuclei of insulin-labeled cells
following massive β-cell loss when averaging the results
across all time points (Supplemental Fig. S1D). Most im-
portantly, the incorporation of BrdU by residual β cells
was not only augmented overall, but it also exhibited a cir-
cadian rhythmicity (adjusted P-value = 0.032; BH.Q=
0.065) when examined using the JTK_Cycle paradigm
(Fig. 1A,B; Supplemental Fig. S2; Hughes et al. 2010).
These data suggest that the proliferative response in resid-
ual β cells after ablation gains a circadian pattern, with a
peak observed in the middle of activity phase.
The acute loss of β-cell mass affects gene expression
in residual β cells, but not in adjacent α cells
In an attempt to explore the mechanism of β-cell prolifer-
ation followingmassive ablation,we profiled the temporal
transcriptome of FACS sorted α- and β-cell populations.
Temporal analyses were conducted 7–10 d following
DOX administration in Insulin-rtTA/TET-DTA-triple-re-
porter transgenicmice.Remnant isletswere isolated every
4 h at six time points across 24 h (Supplemental Fig. S1A,B;
Petrenko et al. 2017a; Petrenko and Dibner 2018). α-Cell
and β-cell fractions fromDOXgroup and untreated control
counterparts were subjected to genome-wide transcrip-
tome analysis by RNA sequencing (RNA-seq). We identi-
fied 12,912 transcripts after filtering for genes with at
least 1 count per million (CPM) in at least half of all mea-
surements (cell type, condition, and time points). Amulti-
dimensional scaling with a distance measure for
microarrays (plotMDS from limma [Ritchie et al. 2015])
run on all samples showed clear separation between α
and β cells (Fig. 2A, dimension 1) andmajor differences be-
tween β cells in intact islets and residual β cells following
ablation (Fig. 2A, dimension 2). In contrast, almost no
Circadian clocks drive β-cell regeneration
GENES & DEVELOPMENT 1651
 Cold Spring Harbor Laboratory Press on December 2, 2020 - Published by genesdev.cshlp.orgDownloaded from 
differences among α-cell samples were detected between
control and DOX groups (Fig. 2A, dimension 2).
Differential transcript expression analysis that com-
pared average values across all six time points per cell
type and per condition identified 924 differentially ex-
pressed genesbetween residual β cells fromtheDOXgroup
and the untreated control counterparts (733 up-regulated
and 268 down-regulated) (Fig. 2B; Supplemental Data Set
S1). In contrast, only one gene (B2m) was differentially ex-
pressed in neighboring α cells after ablation as compared
with controls (Supplemental Data Set S1). We next vali-
dated the changes of selected transcripts differentially ex-
pressed in β cells from the DOX group in an independent
set of experimental animals by qRT-PCR analyses. Con-
cordant with the RNA-seq results, miKi67, AurkB, and
Pappa2 were up-regulated, whereas Mafawas down-regu-
lated (Fig. 2C). Ingenuity pathway analysis (IPA) identified
in the top canonical pathways characterizing the tran-
scriptional landscape of the residual β cells the signaling
pathways involved in cell cycle regulation. Based on the
observed regulation of their molecular components, these
were predicted as activated (Fig. 2D). Moreover, Foxm1
was predicted as a top upstream transcriptional regulator
for the observed regulatory landscape (Fig. 2E).
When the analysis was conducted separately per time
point, the number of differentially expressed transcripts
(Supplemental Fig. S3A) was similarly distributed in β
cells compared with α cells in the control condition (Sup-
plemental Fig. S3B). Small differences across the time
points were observed between α and residual β cells in
the DOX group (Supplemental Fig. S3C–E). In contrast,
the number of differentially regulated transcripts in β cells
between DOX-treated and control mice varied greatly
among the time points (Fig. 2F). There was a higher num-
ber of differentially expressed transcripts observed during
the inactivity phase (between ZT0 and ZT8), and a mini-
mal number of differentially expressed transcripts at the
time point of light to dark transition (ZT12) (Fig. 2F). All
in all, our findings suggest that transcripts whose expres-
sion levels change after β-cell ablation exhibit daily
variability.
The temporal expression of transcripts is differentially
affected in residual β- and neighboring α cells following
massive β-cell loss
To study temporal regulation of α- and β-cell transcrip-
tional landscapes we analyzed RNA-seq data sets collect-
ed at six time points every 4 h across 24 h from DOX
Insulin-rtTA/TET-DTA-triple-reporter mice following
β-cell ablation and the untreated CTR counterparts (Sup-
plemental Fig. S1A; Supplemental Data Sets S2–S5). The
rhythmicity of each gene was determined based on the
best circadian profile with a 20- to 28-h period and a clas-
sification by logistic regression (Materials and Methods).
Temporal gene expression profiles were grouped into a
number of models, which are summarized in Figure 3, E
and F.Heatmaps for five selectedmodels for the alteration
of temporal gene expression between α and β cells in
control and DOX groups are presented in Figure 3, A and
B, respectively. The five groups of profile changes encom-
passed the genes expressed in both cell types that exhibit-
ed a flat (nonrhythmic) profile across 24 h in one cell type,
but a circadian profile in the other cell type (NC and CN,
where N stands for “nonrhythmic” and C stands for “cir-
cadian”). The CC group comprised genes that were rhyth-
mically expressed in both cell types, with similar or
distinct circadian properties. The last two categories re-
ferred to the genes that were not expressed (Ne) in one
cell type but expressed in a circadian fashion in the other
(CNe andNeC). A genewas considered to be expressed if it
had an average RPKM across all time points of >1. Consis-
tent with our previous study (Petrenko et al. 2017b), close
to half of the detected transcripts (45.15%) exhibited a
rhythmic expression in at least one cell type (Fig. 3A; Sup-
plemental Data Set S2). Following massive β-cell loss, the
overall proportion of genes defined as rhythmic in at least
one cell type slightly increased to 48.5%. The number of
rhythmic genes common to both cell types increased
from 1505 to 1645, and the number of transcripts exclu-
sively rhythmic in residual β cells increased from 1668
to 2128 in the DOX group (Fig. 3B; Supplemental Data
Set S3). We next conducted a similar comparison of
BA
Figure 1. Circadian regulation of β-cell regeneration following massive ablation. (A,B) Around-the-clock assessment of β-cell prolifera-
tion conducted 12 d after beginning ofDOX administration. BrdUwas injected intraperitoneally 2 h prior to sacrificing the animals every 4
h across 24 h. (A) Representative confocal images of pancreatic islets show localization of proliferation marker BrdU (red staining) in the
nucleus of insulin-producing β cells (green) at the indicated time points (see also Supplemental Fig. S2). Scale bar, 50 µm. (B) Daily profile of
β-cell proliferation. Data are expressed as mean±SEM for n=3 mice per time point. Two-way ANOVA test with Bonferroni post-test was
used to assess the difference between control and DOX groups. (∗∗) P <0.01, (∗∗∗) P< 0.001. JTK_Cycle was used to assess circadian rhyth-
micity of the averaged profiles.
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Figure 2. Differential analysis of gene expression in α and β cells following massive β-cell ablation. A total of 12,912 transcripts were
identified by RNA-seq analyses, following the experimental settings presented in Supplemental Figure S1A. (A) Multidimensional scaling
across all the samples (α and β cells from mice treated or not with DOX in six time points, two experimental repetition each, total of 24
samples). (Dimension 1) Cell type, (dimension 2) treatment (DOX vsCTR). “C.A” and “C. B” (experimental repetition 1 and 2) correspond
to α and β cells, respectively, from the CTR group; D.A and D. B (repetition 1 and 2) correspond to the DOX group counterparts. Note the
clear separation between the transcripts specific for α and β cells, and between CTR and DOX β cells. (B) Volcano plot presents transcripts
that were differentially expressed between CTR β cells and residual β cells in DOX group. For differential analysis, the average across six
time points per each of four conditions (α and β cells, treated or not with DOX) was considered. Up-regulated genes (924 genes) are labeled
in green; down-regulated (190 genes) are labeled in red (log2FC>0.5 and log2FC<−0.5, respectively). Sizes of dots correspond to the log10 P-
value. Volcano plots that compare α and β cells in control andDOX groups are presented in Supplemental Figure S3, A andC, respectively.
(C ) Examples of differentially expressed genes in β cells following ablation identified by RNA-seq (shown in B) and assessed by qRT-PCR
analysis in an independent set of mice. Data are expressed as mean±SEM for n =4–9 mice. (∗) P <0.05, (∗∗) P <0.01, (∗∗∗) P <0.001. (D,E)
Results of the Ingenuity PathwayAnalysis (IPA) of differentially expressed transcripts (shown in B), indicating the top canonical pathways
predicted regulated (z≥ 1.8) as well as the overlapping canonical pathways map with at least five common molecules (D) and the top ac-
tivated predicted upstream transcription regulators (z≥ 2) (E). (F ) Histograms presenting differential expression (number of up- and down-
regulated genes) in residual β cells (DB) comparedwith control condition (CB) at each of six time points. See Supplemental Figure S1 for the
experimental design and related Supplemental Figure S3.
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Figure 3. Temporal analysis of gene expression in α and residual β cells following partial β-cell ablation. (A–D) Heat maps comparing
temporal profiles of transcripts between α and β cells in control condition (A) or following β-cell ablation (DOX condition; B), between
α cells in control and DOX groups (C ), and between β cells (D) in control and DOX groups for the temporal transcript profile changes
from nonrhythmic to circadian (NC), circadian to nonrhythmic (CN), circadian rhythmic in both conditions (CC), nonexpressed in one
condition and circadian rhythmic in the other (NeC and CNe), nonexpressed in one condition and nonrhythmic in the other (NeN and
NNe), and nonexpressed in both conditions (NeNe). (E,F ) IPA of different models of rhythmic transcripts expressed in β cells (E) and in
α cells (F ), in control versus DOX-treated conditions. Three predicted upstream regulators (blue) and threemost enriched functional path-
ways are listed next to themodel drawings. For data sets too small to allow pathway analysis, a selection of genes belonging to the respec-
tive model is indicated (green). (G) IPA of sub-groups of rhythmic transcripts (Fig. 3C, models CC, NC, CN, NeC, and CNe) that were
differentially expressed in β cells between control and DOX-treated conditions. Predicted upstream regulators (blue) are listed next to
the schematic drawing of the temporal profile change. For data sets too small to allow pathway analysis, a selection of DEGs (green) is
indicated. Top canonical pathways, disease, and molecular/cellular function are listed below the drawing. (H) Leading IPA-generated or-
ganic network of up-regulated and down-regulated transcripts that acquired rhythmicity following DOX treatment in the model NC in
presented in G displaying the regulation of cell cycle related genes.
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temporal gene expression in each cell type between con-
trol and DOX conditions (Fig. 3C,D). In the β-cell fraction,
1635 genes that were circadianly expressed in the control
lost their rhythmic expression in the DOX group (Fig.
3C; Supplemental Data Set S4, model CN). Remarkably,
2208 transcripts that were nonrhythmic in the control
group acquired rhythmicity after ablation (Fig. 3C; Supple-
mental Data Set S4, model NC). Noteworthy, despite the
lack of differential changes in the average values of the
transcript expression across all the time points in α cells
following DOX treatment, the ablation of neighboring β
cells strongly affected the temporal landscape of the α-
cell transcriptome. Indeed, 2266 transcripts that were
rhythmic in the control group became flat in the DOX
group (Fig. 3D,model CN), and asmany as 2225 nonrhyth-
mic transcripts in the control α cells acquired a rhythmi-
city in DOX-treated mice (Fig. 3D, model NC;
Supplemental Data Set S5).
We next performed pathway analysis by applying IPA to
each of the five groups of transcripts that presented tem-
poral profile changes in β and α cells between the control
and DOX groups (Fig. 3E,F, respectively, referring to the
temporal heatmaps in Fig. 3C,D). Interestingly, nonrhyth-
mic transcripts that acquired rhythmicity in residual β
cells were involved into Sirtuin signaling, tRNA charging,
and estrogen receptor (ESR) signaling (Fig. 3E). Those in
neighboring α cells were related to ESR and PTEN signal-
ing, and to molecular mechanisms related to cancer (Fig.
3F). In turn, rhythmic transcripts that lost rhythmicity
in residual β cells were related to mitochondrial dysfunc-
tions, oxidative phosphorylation, and xenobiotic metabo-
lism. Those in neighboring α- cells were related to mTOR
signaling, to EIF2 signaling, and to the regulation of eIF4
and the ribosomal protein p70S6k, which are involved in
the tuning of protein synthesis.
Two additional groups of genes were identified in each
cell type: (1) genes that were defined as nonexpressed in
control condition, and that were up-regulated and ac-
quired rhythmic profiles following DOX treatment (mod-
el NeC in Fig. 3E,F); and (2) rhythmically expressed genes
in the control condition that became silent following
DOX treatment (model CNe in Fig. 3E,F). Interestingly,
newly expressed rhythmic genes in residual β cells were
related to mitosis, with the mitotic role of Polo-like ki-
nase, cell cycle control of chromosome replication, and es-
trogen-mediated S-phase reentry signaling being
identified as the top three canonical pathways (Fig. 3E).
Finally, we applied IPA to the genes that were both dif-
ferentially expressed according to the analyses of mean
values (Fig. 2B) and exhibited distinct temporal rhythmic
profiles in β cells following the β-cell ablation compared
with the control group (Fig. 3C). Strikingly, a high number
of genes coding for the key regulators of the cell cyclewere
comprised in this group. The transcripts of cell cycle reg-
ulators exhibited higher expression in residual β cells (Fig.
2B) and became rhythmic after ablation (models NC and
NeC in Fig. 3G,H). This further supports the possibility
that compensatory β-cell proliferation is controlled in a
circadian fashion. Accordingly, the top-rated network of
differentially expressed genes within the NC model con-
sisted of genes involved in cell cycle regulation (Fig. 3H),
further substantiating the role of circadian regulation in
the proliferation of β cells during regeneration.
The temporal expression of core clock and cell cycle-
controlling genes in residual β cells and adjacent α cells
following β-cell ablation
Remarkably, a comparison of the circadian phases be-
tween the transcripts that exhibited rhythmic expression
profiles in control and DOX groups in β cells (Fig. 3C) re-
vealed that most of the transcripts rhythmic in the DOX
group had a phase delay of ∼2.5 h when compared with
the corresponding transcripts of the control group (Fig.
4A, red bars; Supplemental Data Set S6). In contrast, no
significant phase shifts were found for the transcripts
that were rhythmically expressed in α cells between con-
trol and DOX conditions (Fig. 4A, green bars; Supplemen-
tal Data Set S6).
To address the question of whether the core clock ma-
chinery operative in the islet cells had been altered by
massive β-cell ablation, we compared profiles of the core
clock components in DOX and control groups in α and β
cells. Rorc, Bmal1 (Arntl), and Cry1 oscillatory profiles
were phase-advanced in β cells compared with α cells in
untreated control mice, concordant with our previous
findings (Petrenko et al. 2017b). Noteworthy, these tran-
script profiles were phase-delayed in β cells following
DOX treatment when compared with β cells of untreated
mice. However, these phase differences could not be ob-
served in the neighboring α cells (Fig. 4B). This finding
was further supported by a KEGG pathway enrichment
analysis of RNA-seq database (Supplemental Data Set
S6), with circadian clock pathway appearing among the
most altered ones (Supplemental Fig. S4A). We next as-
sessed themolecular clockwork in isolated remnant islets
after massive β-cell ablation and in separated α and β cells
synchronized by a forskolin pulse in vitro (Supplemental
Fig. S4B,C). These experiments suggest that cell-autono-
mous molecular clocks are fully operative in isolated α
and β cells of remnant pancreatic islets following massive
β-cell ablation.
An additional prominent group of transcripts whose ac-
cumulation appeared altered followingDOX treatment by
IPA analysis was related to the regulation of the cell cycle.
Noteworthy, most of the up-regulated cell cycle-related
transcripts exhibited a circadian expression profile (see
Fig. 3G). These transcripts include mRNAs encoding the
proliferation regulatorsmKi67, Foxm1, Pbk, E2f2, cyclins
(Ccna2 and Ccnb2), aurora kinases (Aurkb and Aurka),
Cdk1, Cdc20, and other regulators of cellular cycle pro-
gression (Fig. 4C; Supplemental Data Set S3).
The essential core clock transcription factor BMAL1
is required for β-cell proliferation following massive
β-cell ablation
To scrutinize the role of themolecular clocks in the devel-
opment of diabetic phenotypes and in the regulation of
compensatory β-cell regeneration, β-cell ablation was
Circadian clocks drive β-cell regeneration
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triggered in arrhythmic Bmal1 deficient mice. To this
end, we crossed mice in which BMAL1 expression was
blocked by a transcriptional-translational stop cassette
knock-in into the Bmal1 locus (Bmal1st/st mice) (Supple-
mental Fig. S5A) with Insulin-rtTA/TET-DTA-triple-re-
porter mice. As expected, the absence of functional
clocks in isolated islets from these transgenic animals re-
sulted in a flat Per2-luc bioluminescence profile following
forskolin synchronization (Supplemental Fig. S5B). Clock-
compromised Bmal1st/stDTA mice and their heterozy-
gous Bmal1+/stDTA counterparts were treated with
DOX according to the design depicted in Supplemental
Figure S1A. Of note, nontreated Bmal1+/st mice and their
Bmal1+/+ counterparts exhibited comparable levels of glu-
cose, insulin, and glucagon (Supplemental Fig. S6A–C).
Induction of β-cell loss in Bmal1st/st mice led to a sig-
nificantly more severe hyperglycemia as compared with
DOX-treated heterozygous mice (Fig. 5A, cf. Bmal1+/
stDOX and Bmal1st/stDOX). Thus, in DOX-treated
Bmal1st/stDTA animals, peripheral blood glycemia was
∼10 mmol/L higher than in heterozygotes control mice
in the middle of the activity phase (ZT16). This difference
was slightly smaller, but still significant, at ZT4 (Fig. 5A).
Bmal1st/stDTA and heterozygotes mice exhibited similar
levels of hypoinsulinemia after DOX treatment at ZT16
as compared with nontreated Bmal1st/stDTA and control
mice, with no significant changes in blood insulin ob-
served at ZT4 (Fig. 5A). Bmal1st/stDTA mice not treated
with DOX exhibited higher levels of blood glucagon as
compared with the clock proficient controls. Strikingly,
β-cell ablation resulted in a significantly more dramatic
hyperglucagonemia in Bmal1+/stDTA mice at ZT16.
This phenotype was even more pronounced in Bmal1st/
stDTA mice. A trend for hyperglucagonemia was also ob-
served forBmal1+/stDTA andBmal1st/stDTAmice treated
with DOX at ZT4; however this tendency did not reach




























































































































































































































































































































































Figure 4. Temporal profiles of core clock and proliferation regulating genes in residual β cells and adjacent α cells following massive ab-
lation. (A) Phase shift between rhythmically expressed transcripts in CTR and DOX conditions (model CC) identified in α cells (in green)
and β cells (in red) according to the temporal analysis of RNA-seq presented in Figure 3. Phase differences were calculated for each rhyth-
mic transcript and plotted on the graph. 0 corresponds to identical phase between the transcript expression in CTR and DOX conditions.
(B) Temporal profiles of selected core clock transcripts (RorC,Arntl [Bmal1], andCry1) in control α and β cells (in green and in red, respec-
tively; left panels), in control β cells versus residual counterparts (middle panels), and in control and DOX-treated α cells (right panels)
assessed by RNA-seq. (C ) Temporal profiles of selected transcripts encoding for the proliferation regulating proteins (see also Fig. 3G)
in sorted β cells. Data are expressed as mean±SD for two experimental repetitions per each time point with at least three mice in each
plicate.
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Figure 5. Bmal1 is required for functional recovery and compensatory β-cell proliferation followingmassive β-cell loss. (A) Assessment of
blood glucose, insulin and glucagon levels 12 d after beginning ofDOXadministration atZT16 andZT4.Data are expressed asmean±SEM
for n=8–16 mice per group. One-way ANOVA was applied to test the difference between groups, followed by t-test comparisons. (∗) P<
0.05, (∗∗) P <0.01, (∗∗∗) P< 0.001, (∗∗∗∗) P <0.0001. (B,C ) β-Cell proliferation 12 d following DOX administration, assessed by 2-h BrdU pulse
prior to sacrificing at ZT0. Representative confocal images of pancreatic islets (B) showing the colocalization of proliferationmarker BrdU
(red staining) with nuclei of insulin-producing β cells (green) (see also Supplemental Fig. S7); and corresponding histogram (C ) showing
quantification of double-positive cells within insulin-labeled populations. Data are expressed as mean±SEM for n =4–6 mice per pheno-
type. One-way ANOVAwas applied to test the difference between groups, followed by t-test comparisons. (∗) P <0.05, (∗∗) P<0.01. (D) As-
sessment of blood glucose, insulin and glucagon at ZT4, onemonth after withdrawing DOX.Data are expressed asmean± SEM for n=4–9
mice per phenotype. One-way ANOVA was applied to test the difference between groups, followed by t-test comparisons. (∗) P<0.05,
(∗∗) P <0.01, (∗∗∗) P <0.001, (∗∗∗∗) P<0.0001. (E,F ) Representative confocal images of islets on pancreatic sections (E) showing α- and β-
cell composition (stained for glucagon in red and for insulin in green, respectively) of the islets from Bmal1st/st and Bmal1+/st mice one
month after DOX withdrawal (Bmal1st/stDOX and Bmal1+/stDOX, respectively). Control (Bmal1+/st) and Bmal1st/st mice did not receive
DOX treatment. Percentage of insulin-labeled β-cell out of total number of α and β cells is presented in adjacent histogram (F ). Data are
expressed as mean±SEM for n =2–7 mice per phenotype. A one-way ANOVAwas applied to test the difference between groups, followed
by t-test comparisons (except for Bmal1+/st). (∗∗) P<0.01, (∗∗∗) P <0.001. Scale bars in B and E, 50 µm.
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Next, we assessed the proliferation rate of remnant β
cells by injecting the thymidine analog BrdU intraperito-
neally 2 h before sacrificing the animals at ZT0. In agree-
ment with our previous data (Fig. 1A,B), the number of
BrdU/Insulin double-positive β cells was significantly in-
creased in DOX-treated Bmal1+/stDTA mice following β-
cell ablation as compared with both Bmal1+/stDTA and
Bmal1st/stDTA control mice without DOX treatment
(Fig. 5B,C). In striking contrast, β-cell loss failed to en-
hance the number of BrdU/Insulin double-positive cells
in DOX-treated Bmal1st/stDTA (Bmal1st/stDOX) (Fig. 5B,
C; Supplemental Fig. S7).
Finally, we followed the regeneration and functional re-
covery of β cells during a longer period after massive abla-
tion. Four weeks after DOX withdrawal the blood glucose
levels measured at ZT4 in Bmal1st/stDTA animals stayed
consistently high when compared with Bmal1+/stDTA
counterparts (Fig. 5D, left panel, cf. Bmal1st/stDOX and
Bmal1+/stDOX). The level of serum insulin was compara-
ble between DOX-treated Bmal1+/stDTA and Bmal1st/st
DTA animals, with a tendency to be lower in Bmal1st/st
group that did not reach statistical significance (Fig. 5D,
middle panel). Furthermore, untreated Bmal1st/stDTA
mice exhibited a significantlymore pronounced hyperglu-
cagonemia as compared with heterozygous controls. Ob-
served hyperglucagonemia was further elevated in DOX
treated Bmal1st/stDTA animals compared with their
Bmal1st/st counterparts without such a treatment (Fig.
5D, right panel).
Strikingly, 6wk followingDOXwithdrawal the survival
rate for Bmal1st/stDTA animals was ∼33% only (three out
of ninemice), whereas all of the Bmal1+/stDTA animals (n
= 8) survived at this point.Consistentwith the blood glyce-
mia and hormone status, histological examination of the
pancreas from the animals following 6wkof recovery after
DOXadministration revealed a significantly lower propor-
tion of insulin-positive β cells in Bmal1st/stDTA mice
among overall insulin- and glucagon-labeled cells as com-
pared with their Bmal1+/st counterparts (Fig. 5E,F, cf.
Bmal1st/stDOX and Bmal1+/stDOX). Hence, in contrast
to the β-cell regeneration and recovery from diabetes ob-
served in rhythmicmice, β-cell regeneration did not occur
in Bmal1st/st arrhythmicmice. Consequently, this led to a
life-threatening diabetes,with pronouncedhyperglycemia
and hyperglucagonemia.
The expression of cell cycle-regulating genes is strongly
inhibited in residual β cells of Bmal1st/stDTA mice
following β-cell ablation
In an attempt to dissect the molecular mechanism under-
lying the failure of β-cell regeneration in the absence of the
core clock transcription factor BMAL1, we performed
RNA-seq on FACS-purified residual β cells from
Bmal1st/stDTA mice 10 d following DOX administration
(Fig. 6A; Supplemental Data Set S7). First, we compared
DOX-treated Bmal1st/stDTA with untreated controls
(Supplemental Data Set S8). We identified only three dif-
ferentially expressed genes between these two conditions:
transcripts related to fructose metabolism Aldob and
Pfkfb3were up-regulated, whileH2-Ea-pswas down-regu-
lated. We failed to observe activation of cell cycle related
pathways. When compared DOX-treated Bmal1st/stDTA
and Bmal1+/stDTA mice, an impaired expression of func-
tional Bmal1 pre-mRNA in Bmal1st/stDTAmicewas con-
firmed by a decreased RNA sequence read coverage of the
Bmal1 gene region downstream from the stop cassette (be-
tween exon 5 and 6) as compared with heterozygotesmice
(Supplemental Fig. S5A,C). An up-regulation of incom-
plete Bmal1 transcript was observed in Bmal1st/st mice
(Supplemental Fig. S5E,F; Supplemental Data Set S7), sup-
posedly because the expression levels of REV-ERBα/β, that
act as repressors of Bmal1 transcription (Preitner et al.
2002), were diminished in these animals (Supplemental
Data Set S7).
Within all of the detected 14,649 expressed genes, a sub-
set of 319 differentially expressed genes (DEGs) defined by
FC≥ 2 with P< 0.05 was identified between homozygous
Bmal1st/stDTA and heterozygous Bmal1+/stDTA counter-
parts (Fig. 6B,C). The IPA of this DEG subset revealed reg-
ulators involved in cell cycle regulation and circadian
rhythm in the top 5 canonical pathways (Fig. 6D, green is-
land; Supplemenal Fig. S5D). KEGG pathway enrichment
analysis revealed a differential expression of modulators
of the neuroactive ligand-receptor interaction pathway,
comprising key hormonal regulators of β-cell function
Gcgr and Ptger3 up-regulation and Glp1r, Oxtr, Ucn3,
and Lpar6 down-regulation (Supplemental Fig. S5G; Sup-
plemental Data Set S7). Functional networks directly
linked to impairedBmal1 expression are presented in Sup-
plemental Figure S5, E andF.
Furthermore, based on the observed changes, the path-
ways involved in cell cycle regulation were predicted as
inhibited (Supplemental Fig. S5D), suggesting a decreased
β-cell proliferation in the Bmal1st/st mice. Supporting this
observation, key cell cycle regulators such as senescence
markers Cdkn2a (p16) and Cdkn1a (p21, P-value of over-
lap 6.82E-28, activation z-score 2.701) and tumor suppres-
sor genes p53 and p73, were inferred in the top predicted
upstream transcription regulators with expected activa-
tion (Fig. 6E). Furthermore, CcnD1 (cyclin D1) (Fig. 6E)
and Foxm1 (Fig. 6E,F) were included in the top predicted
upstream regulators inferred as inhibited. Accordingly,
cell cycle progression was identified as a top molecular
and cellular function of the analyzed DEG set, while can-
cer was suggested to be the leading predicted associated
pathology (Fig. 6E). Strikingly, all three top hits revealed
by the network analysis were connected to cell cycle reg-
ulation (Fig. 6F). Taken together, these findings may ex-
plain the low proliferative potential of Bmal1 deficient β
cells after β-cell ablation (Fig. 5B,C, E,F).
Discussion
In this study, we induced massive β-cell ablation to iden-
tify mechanisms participating in the regulation of islet
cell regeneration and to characterize the transcriptional
landscape in separated α cells and residual β cells. Our re-
sults provide evidence that proliferation of residual β cells
Petrenko et al.
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triggered by massive ablation follows a circadian pattern
(Fig. 1). Virtually no compensatory β-cell regeneration oc-
curred in arrhythmic Bmal1st/st mice that may suggest a
role of the functional oscillators in coordinating β-cell
division. Importantly, massive β-cell ablation led to a fatal
noncompensated diabetes in the absence of the core clock
transcription factor BMAL1 (Fig. 5).
Coupling between the circadian clock and β-cell
proliferation
Replication of terminally differentiated β cells, rather
than differentiation of stem cells, represents a major
source of newly generated β cells after birth. This holds
true not only under physiological conditions, but also dur-
ing regeneration following lesions (Dor et al. 2004; Bren-
nand et al. 2007; Nir et al. 2007; Teta et al. 2007;
Klochendler et al. 2016). Noteworthy, in the absence of re-
sidual β-cell upon near-total ablation the conversion of α
or δ cells into insulin-producing cells was also described
(Thorel et al. 2010; Chera et al. 2014). Our data indicate
that β-cell reparative proliferation follows a daily rhythm
and that it requires functional core clock protein Bmal1
(Figs. 1, 5). We now show that the highest proliferation
rate occurs during the activity phase in themiddle of night
(Fig. 1), and that it coincides with the peaks of rhythmic
expression of the genes encoding key regulators of the
cell cycle (Fig. 4B). Importantly, whole-body knockout of
the core clock component BMAL1 strongly disrupts β
cells regeneration following massive ablation in transgen-
ic mice (Fig. 5). A β-cell-specific disruption of the Bmal1




Figure 6. RNA-seq analysis of residual β cells in Bmal1st/st mice followingmassive β-cell loss. (A) Schematic drawing of RNA-seq differ-
ential analysis of FACS-separated β cells from Bmal1st/st and Bmal1+/st mice treated with DOX. Data represent two biological replicates
collected at ZT0 (each replicate is a mix of cells from three mice). (B) Volcano plot presenting 319 differentially expressed transcripts
(showing significance [−log10 {P-valuewith FDR}] versus fold change [logFC]). Vertical lines highlight log2 fold changes of −2 and +2, while
a horizontal line represents a P-value with FDR of 0.05. (C ) Dendrogram with heat maps highlighting clusters of up-regulated and down-
regulated genes between Bmal1st/st and Bmal1+/st mice treated with DOX in two biological replicates (a and b). (D–F ) The IPA of differ-
entially expressed genes, revealing the overlapping canonical pathways map (minimum number of commonmolecules: four;D); top pre-
dicted upstream transcription regulators (activated or inhibited), topmolecular and cellular function, and top disease and disorders (E); and
the top 1 network (F ) of the analyzed differential transcriptional landscape, all suggesting the modulation of cell cycle regulation in
Bmal1st/st mice.
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induced expansion of β-cell mass (Rakshit et al. 2016).
These previously published data suggest that the lack of
β-cell mass expansion following diet-induced obesity
takes place in the absence of at least one allele of Bmal1
in β cells, and it is likely attributed to the increased cell
death, rather than to decreased proliferation per se. More-
over, it is important to highlight that expansion of β-cell
mass upon obesity and β-cell regeneration have a different
nature. In contrast to the expansion of β cells upon obesi-
ty, we show that regeneration requires functional clock
and it is still present in rhythmic mice heterozygotes for
Bmal1.
We found that a number of the up-regulated cell cycle-
related transcripts exhibited a circadian rhythmicity in re-
sidual β cells following ablation (Fig. 4C) and were likely
under the positive control of the transcription factor
FOXM1 (Fig. 2E). The transcription of Foxm1 itself was
circadian and peaked in themiddle of the active phase, co-
inciding with the peak of proliferation (Fig. 4C–E). Strik-
ingly, unlike heterozygous animals, no up-regulation of
Foxm1 mRNA and transcripts specifying other cell cycle
regulators was observed in Bmal1st/stmice followingmas-
sive β-cell ablation, as compared with their nontreated
counterparts (used as controls) (Fig. 6F; Supplemental
Data Set S8). This provides a mechanistic basis for the
lack of β-cell regeneration (Fig. 5E,F) and further suggests
a key role of circadian clocks in the expression of cell cycle
genes. FOXM1 is one of the key transcription factors re-
quired for postnatal β-cell proliferation, but not for neo-
genesis of β cells from progenitors (Zhang et al. 2006;
Ackermann Misfeldt et al. 2008). Its expression is en-
hanced in different models of β-cell expansion associated
with obesity (Davis et al. 2010; Yamamoto et al. 2017),
pregnancy (Zhang et al. 2010) and regeneration following
partial pancreatectomy (Ackermann Misfeldt et al.
2008). Moreover, induction of the activated form of
FOXM1 restored the replicative potential of β cells in
aged animals (Golson et al. 2015). Finally, stimulation of
cell proliferation in juvenile human islets by activation
of GLP-1r signaling triggered the expression of Foxm1.
This makes FOXM1 a molecular candidate for coupling
the cell cycle to molecular clocks. The precise mechanis-
tic details of these interactions need to be elucidated in fu-
ture work.
Proliferating β cells bear functional clocks
In adulthood, both α and β cells possess cell-autonomous
and self-sustained circadian oscillators in mice and hu-
mans (Pulimeno et al. 2013; Petrenko et al. 2017b; Pet-
renko and Dibner 2018). Here we report that in adult
mice the residual β cells maintain a circadian rhythmicity
both in vivo and in vitro following ablation (Fig. 4B; Sup-
plemental Fig. S4B,C). The characteristics of rhythmic ex-
pression patterns of selected core clock genes (Arntl,
RorC, and Cry1) in residual β cells of DOX-treated mice
were, however, altered when compared with nontreated
mice (Fig. 4B; Supplemental Fig. S4A). These differences
may stem from β-cell proliferation, similar to what has
previously been reported for dividing and nondividing
NIH3T3 fibroblasts (Nagoshi et al. 2004). Alternatively,
altered paracrine or systemic signals along with the ob-
served changes in the molecular landscape of residual β
cells may lead to differences in the resetting of the molec-
ular oscillator in residual β cells. For example, the loss of β
cells leads to an enhanced proportion of neighboring α
cells and an augmented secretion of glucagon (Fig. 5A), a
potential synchronizer of molecular clocks in β cells (Pet-
renko and Dibner 2018).
Interestingly, residual β cells exhibited decreased levels
of the mRNA encoding the important differentiation reg-
ulator MafA (Fig. 2B,C). This may be the consequence of
dedifferentiation and dysfunction of these cells (Wang
et al. 2007; Aguayo-Mazzucato et al. 2011; Swisa et al.
2017). Moreover, the circadian amplitude and magnitude
of MafA mRNA accumulation were attenuated (Supple-
mental Fig. S4D) in DOX-treated mice. Besides core clock
transcripts and MafA mRNA, numerous groups of tran-
scripts changed their temporal expression profiles in resid-
ual β cells and neighboring α cells (Fig. 3), suggesting a
modified temporal transcription landscape within regen-
erating islets upon diabetes.
Activation of β-cell regeneration following ablation
Themassive β-cell loss induced the transcription of genes
involved in cell cycle progression and replication in the re-
sidual β cells (Fig. 2D; SupplementalData Set S3; Dor et al.
2004), but not in neighboring α cells (Fig. 2A). Likewise,
the activation of GLP-1 signaling by exendine-4 exclusive-
ly induced proliferation in β-cell, and not in α or δ cells
(Dai et al. 2017). This raises the question of which
β-cell-specific mitogenic signals become important after
β-cell ablation. The function of pancreatic islet is regulat-
ed by systemic and paracrine stimuli mediating distinct
cell type-specific effects (Koh et al. 2012; Petrenko et al.
2018). Such differences in receptor repertoire and signal-
ing molecules between α and β cells also define the cell-
specific entrainment of circadian oscillators by physiolog-
ically relevant inputs that may regulate coupling between
cell cycle and circadian oscillators (Petrenko et al. 2017b;
Petrenko and Dibner 2018). In addition, the difference in
glucose sensing and metabolism in α and β cells (Olsen
et al. 2005) may account for the cell type-specific activa-
tion of β-cell proliferation. Indeed, high glucose plays a
role in triggering β-cell proliferation capacity via the glu-
cose sensor glucokinase (Porat et al. 2011). This conjunc-
tion may involve the molecular clocks machinery, as the
core clock component RORγwas reported to regulate glu-
cose-stimulated proliferation in INS-1E cells in vitro
(Schmidt et al. 2016). Concordantly, our data indicate
that the enhanced proliferation rate following β-cell abla-
tion parallels a hyperglycemia. Nonetheless, no signifi-
cant proliferation of residual β cells was induced
following ablation in absence of BMAL1, although the lev-
els of glycemia were even higher in Bmal1st/st animals.
These data suggest that high glucose alone is insufficient
to trigger proliferation of β cells, and that functional oscil-
lators are required to induce β-cell proliferation. We wish
to emphasize, however, that we do not know whether the
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effects on glucose metabolism and β-cell proliferation ob-
served in Bmal1st/st mice (Figs. 5, 6) were attributed to the
elimination of the transcriptional factor BMAL1 per se, or
to its function as a key core clock regulator. The discrim-
ination between circadian and noncircadian activities
of core clock transcription factors has been a notoriously
difficult problem in the field. So-called “resonance exper-
iments,” in which phenotypes are compared in organisms
whose oscillators do or do not resonate with environmen-
tal cycles (T cycles), are probably the only approaches re-
vealing the importance of rhythmic functions (Ma et al.
2013). Unfortunately, such endeavors are not feasible in
the system described here.
Elegant work by Okamura and colleagues (Matsuo et al.
2003) reported that the initiation of mitotic division in re-
generating mouse livers follows a robust circadian
rhythm. These investigators provided compelling evi-
dence that rhythmic cell cycle progression in regenerating
livers is governed by the circadian expression of Wee1, a
key regulator of mitosis. Interestingly, the kinetics of S-
phase hepatocytes was not controlled bymolecular clock.
In our study, the kinetics of S-phase regenerating β cells
was circadian, and the temporal expression levels of
Wee1 transcript were rhythmic in β cells in both control
and DOX conditions, with absolute levels being un-
changed (Supplemental Fig. S4E). Wee1 expression exhib-
ited a tendency for down-regulation in Bmal1st/st mice as
compared with Bmal1+/st controls (FC=−1.45) (Supple-
mental Data Set S7) that did not reach statistical signifi-
cance. Moreover, liver regeneration was delayed, but not
arrested, in arrhythmicCry1/Cry2 knockoutmice. In con-
trast, the regeneration of pancreatic β cells did not proceed
in the absence of the essential core clock component
BMAL1, leading to fatal diabetes in a high proportion of
animals (Fig. 5).
Systemic loss of BMAL1 aggravates diabetes
Disruption of the core clock components impairs insulin
secretion by mouse and human β cells (Perelis et al. 2015;
Petrenko et al. 2020) and results in a diabetic phenotype in
mice (Marcheva et al. 2010). We now demonstrate that in
the absence of a functional clockmice develop severe fatal
diabetes following massive β-cell loss, contrary to their
rhythmic counterparts that partially recover from thus-in-
duced diabetes (Fig. 5D–F; Nir et al. 2007). While we failed
to demonstrate a difference in blood insulin levels be-
tween Bmal1st/st mice and heterozygotes counterparts at
the examined time points, arrhythmic animals developed
strong hyperglucagonemia (Fig. 5D). Since glucagon stim-
ulates gluconeogenesis in the liver (Perry et al. 2020), this
may contribute to the strongly elevated blood glucose lev-
els followingmassive β-cell ablation in Bmal1st/st mice. In
addition, loss of functional clocks evoked insulin resis-
tance in skeletal muscles (Dyar et al. 2014; Harfmann
et al. 2016) and impaired cell-autonomous adoptative
changes to increased insulin needs upon diet-induced obe-
sity (Rakshit et al. 2016). Taken together, these data sug-
gest that complex interaction between different
pathogenetic pathways in pancreatic islets and metabolic
tissuesmay account for the deterioration of diabetes upon
dysfunctional clocks.
In summary, our data strongly suggest that regeneration
of β cells is tightly coupled to diurnal rhythm. Moreover,
loss of functional clocks aggravates the development of di-
abetic phenotype inmice. Indeed, human pancreatic islets
from T2D individuals bear dysfunctional clocks associat-
ed with perturbed temporal regulation of insulin and glu-
cagon secretion (Petrenko et al. 2020). These findings have
important translational potential and should be consid-
ered in patients with T1D and T2D, as reboosting circadi-
an rhythms by lifestyle adaptations may help preventing
the aggravation of the disease.
Materials and methods
Animals
Animal studies were performed according to the regulations of
the veterinary office of the State of Geneva (authorization num-
ber GE/47/19). Experimental mouse strain proGcg-Venus/RIP-
Cherry/PER2::Luc/Insulin-rtTA/TET-DTA was established by
crossing triple reporter mouse line proGcg-Venus/RIP-Cherry/
PER2::Luc (Petrenko et al. 2017b) to Insulin-rtTA/TET-DTA
mice (Supplemental Fig. S1; Nir et al. 2007). ProGcg-Venus and
RIP-Cherry reporters exhibited very high specificity and expres-
sion levels in α and β cells, respectively (Dusaulcy et al. 2016; Pet-
renko et al. 2017a). Bmal1st/st mice were developed by
introducing (knock-in) a transcriptional-translational stop cas-
sette between exons 5 and 6 of the Bmal1 locus, containing a
splice acceptor and a triple repeat of a polyadenylation signal se-
quence, flanked by LoxP sites. Bmal1st/st mice were crossed
to proGcg-Venus/RIP-Cherry/PER2::Luc/Insulin-rtTA/TET-DTA.
The obtained proGcg-Venus/RIP-Cherry/PER2::Luc/Insulin-
rtTA/TET-DTA/Bmal1st/st mice allowed to genetically induce
massive β-cell ablation in the absence of functional clocks by ad-
ministering 300 mg of doxycycline (DOX) in the drinking water
supplemented with 2% sucrose. The control group received
only water supplemented with 2% sucrose. All the experiments
were done in mice aged 6–8 wk, under standard animal housing
conditions with ad libitum access to food and water and under
12-h light/12-h dark cycles (LD; lights on at 7:00 a.m., lights off
at 7:00 p.m.). For the islet isolation and BrdU experiments, male
micewere fed exclusively during the night 10 d prior to the exper-
iment and during the experiment (Supplemental Fig. S1A), allow-
ing to reduce the effect of individual feeding rhythm (Atger et al.
2015). For the islet isolation across the 24-h period, half of the an-
imals were entrained by inverted LD and feeding cycles for 2 wk
preceding the experiments.
Pancreatic islet isolation and separation of α and β cells
Islets of Langerhanswere isolated by standard procedure based on
collagenase (type XI; Sigma) digestion of pancreas followed by
Ficoll purification (Petrenko et al. 2017a). Islet cells were gently
dissociated by 0.05% trypsin (GIBCO) treatment, resuspended
in KRB solution (pH 7.4, supplemented with 0.3% free fatty
acid bovine serum albumin [BSA; Sigma], 1.4 mM glucose, 0.5
mM EDTA). α-Cell and β-cell populations were separated by
flow cytometry fluorescence activated cell sorting (FACS; Astrios
sorter [Beckman Coulter]) based on fluorescence wavelength and
intensity, cell singlet nature, size, and viability as described pre-
viously (Petrenko et al. 2017b).
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RNA sequencing (RNA-seq)
For around-the-clock RNA-seq experiments underlying Figures 2
and 3, total RNAwas prepared fromFACS-sorted α and β cells col-
lected from male proGcg-Venus/RIP-Cherry/PER2::Luc/Insulin-
rtTA/TET-DTA control and DOX-treated mice every 4 h around
the clock in biological duplicates, using RNeasy Plus microkit
(Qiagen). A total of 48 samples, representing RNA pool of three
to six mice each, was prepared. RNA-seq was performed by the
iGE3 Genomics Platform (University of Geneva, Switzerland).
The Illumina TruSeq RNA sample preparation kits were used
for the library preparation with 25–50 ng of total RNA as input.
Library molarity and quality was assessed with Qubit (Life
Technologies) and Tapestation using a DNA high sensitivity
chip (Agilent Technologies). Paired-end reads of 50 bases were
generated using SMART-Seq v4 chemistry on an Illumina HiSeq
2000 (first replicate) and Illumina HiSeq 4000 (second replicate)
sequencers.
For RNA-seq experiments inBmal1st/st mice (Fig. 6), total RNA
was prepared from FACS-sorted β cells collected from males and
females of proGcg-Venus/RIP-Cherry/PER2::Luc/Insulin-rtTA/
TET-DTA/Bmal1st/st mice and their proGcg-Venus/RIP-Cherry/
PER2::Luc/Insulin-rtTA/TET-DTA/Bmal1+/st littermates follow-
ing 10 d of DOX administration at ZT0 in biological duplicates,
using RNeasy Plusmicrokit (Qiagen) (a total of four samples, rep-
resenting RNA pool of ∼7000 cells from three mice each). RNA-
seqwas performed by the iGE3Genomics Platform (University of
Geneva, Switzerland). The Clontech SMARTer ultralow input
RNA was used to generate cDNA followed by Nextera XT kit
for library preparation on samples with low RNA input. Library
molarity and quality was assessed with Qubit (Life Technologies)
andTapestation using aDNAhigh sensitivity chip (Agilent Tech-
nologies). Single-end reads of 50 bases were generated using on an
Illumina HiSeq 4000 sequencer.
RNA-seq data processing and analysis
For around-the-clock gene expression assessments, paired end
reads were aligned to the mouse genome (assembly GRCm38/
mm10) using STAR v2.5.3ausing Gencode vM16 annotation.
The quantification was performed with QTLtools quan (https
://qtltools.github.io/qtltools/). The mapping quality threshold
was set at 255, and the number of mismatches allowed in both
reads together was set at five (reads below these thresholds
were not considered for the quantification) (Dobin et al. 2013).
The genome index was built using Ensembl annotation to im-
prove splice junction’s accuracy. For each Ensembl gene, all of
the exons of the respective annotated protein-coding transcripts
were considered. Using custom Perl script, reads up to one mis-
match were counted considering only reads in the right gene ori-
entation. Both uniquely mapping and multimapping reads were
reported. Normalization and differential expression analysis
were performed with the R/Bioconductor packages edgeR v.3.28
(Robinson et al. 2010) and limma 3.42.2 (Ritchie et al. 2015).
Log2 expression levels were calculated.
For the assessment of differential gene expression in β cells be-
tween Bmal1st/st and Bmal1st/stDOX; and between Bmal1st/
stDOX and Bmal1+/stDOX, a quality control was performed
with FastQCv.0.11.5. Single-end readsweremapped tomouse ge-
nome (assembly GRCm38/mm10) using STAR v.7.0f (Dobin
et al. 2013). The biological quality control was done with Picard-
Tools v.2.21.6. Raw counts were obtained using HTSeq v.0.9.1.
Normalization and differential expression analysis were per-
formed with the R/Bioconductor package edgeR v.3.26.8 (Robin-
son et al. 2010). The overall workflow of RNA-seq analysis is
presented in Supplemental Figure S8.
Differential and temporal analysis
For around-the-clock gene expression assessment, geneswith less
than one CPM in half of the all measurements were discarded.
Differential expression analysis between α and β cells was as-
sessed using the EdgeR and limma packages, following the proto-
col of (Chen et al. 2016). A gene was defined as differentially
expressedwhen the absolute value of the log2 fold change (log2FC)
was >0.5 (same cell type) or 1 (otherwise), and the FDR-corrected
P-value was <0.05 from the resulting differential expression anal-
ysis. Genes were considered as “nonexpressed” (Ne in Fig. 3) if
their respective expression value was below an arbitrary thresh-
old of 1 RPKM averaged over time. Rhythmicity of the transcript
profiles was determined in two steps: First, 17 sin/cos models
with intercept were regressed on each of two independent exper-
iments corresponding to different periods in 20–28 h. The model
with the lowest P-value from the F testwas kept. Second, the gene
was deemed rhythmically expressed based on a logistic regression
model with the previous P-value for the two samples used as the
input. The logistic regression was trained on a gold standard of 31
manually labeled genes (see Supplemental Data Set S9). All fitted
coefficients were significant (P-value < 0.008). Based on a ROC
curve, a cutoff of 0.6 was decided leading to a 95% accuracy on
the golden standard between 0.849 and 0.988. Rhythmic parame-
ters (i.e., phase, period length, and amplitude) can be shared be-
tween the two different cell types and between two conditions
(CTR and DOX).
Differential gene expression analysis for β cells between
Bmal1st/st and Bmal1st/stDOX, and between Bmal1st/stDOX and
Bmal1+/stDOX was assessed using a generalized linear model
with quasi-likelihood F-test of the EdgeR package (v 3.26.8). A
gene was defined as differentially expressed when the absolute
value of the log2 fold change (log2FC) was >1 and the FDR-correct-
ed P-value was <0.05 (Benjamini and Hochberg correction).
Ingenuity pathway analysis (IPA) and KEGG pathway enrichment
analysis
The pathway analyses were generated by Qiagen’s IPA program
(IPA; Qiagen, http://www.qiagen.com/ingenuity). Briefly, the
analyses were performed with the following settings: expression
value type (exp fold change), reference set (ingenuity knowledge
base [genes only]), relationships to consider (direct and indirect re-
lationships), interaction networks (35 molecules/network; 25
networks/analysis), node types (all), data sources (all), confidence
(experimentally observed), species (human, mouse, rat), tissue
and cell lines (all), and mutations (all).
The KEGG pathway enrichment analysis was generated by Da-
tabase for Annotation, Visualization and Integrated Discovery
(DAVID) v6.8 based on the gene lists (Supplemental Data Set
S6) comprising rhythmic genes with phase difference >2 h (Sup-
plemental Fig. S4A), and on the gene list (Supplemental Data
Set S7) comprising differentially expressed genes between
Bmal1st/stDOX and Bmal1+/stDOX phenotypes.
Quantitative polymerase chain reaction (qPCR)
Total RNA was prepared from FACS separated islet cells using
RNeasy Plus microkit (Qiagen). The RNA concentration was
measured by Qubit RNA SH kit (Invitrogen). Next, 0.1 μg of total
RNA was reverse-transcribed using TAKARA (Roche) and ran-
dom hexamers and was PCR-amplified on a LightCycler 480
(RocheDiagnostics AG).Mean values for each samplewere calcu-
lated from technical duplicates of each quantitative RT-PCR
(qRT-PCR) analysis and normalized to the mean of housekeeping
genes hypoxanthine–guanine phosphoribosyltransferase (Hprt)
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and S9. Primers used for this study are listed in Supplemental
Table S1.
Assessment of blood glucose, insulin, and glucagon levels
Blood glucose (Fig. 5) was measured by the Accu-Chek glucome-
ter (Roche). For insulin and glucagon assessment, blood was col-
lected from the tail vein at ZT4 (11:00), or at ZT16 (23:00) with
subsequent serum preparation by immediate centrifugation at
94,000 rcf for 15 min at 4°C and stored at −80°C. Protease inhib-
itors aprotinin (Sigma) and DPP4 (Millipore) were added to the
samples to preserve the hormones from degradation. Insulin
and glucagon concentrations were assessed by ultrasensitive
mouse insulin and glucagon 100μL ELISA kits (Mercodia).
Assessment of cell proliferation
5-bromo-2′-deoxyuridine (BrdU; Sigma-Aldrich) was injected in-
traperitoneally (100 mg/kg) 2 h prior to sacrifice at the indicated
time points.
Immunostaining
Paraffin sections (5 μm thick) were rehydrated, and antigen re-
trieval was performed using a Biocare pressure cooker and citrate
(pH 6) buffer. The following primary antibodies were used: guinea
pig anti-insulin (1:200; Dako), mouse anti-glucagon (1:800;
Abcam), rabbit anti-glucagon (1:8000; Abcam), and mouse anti-
BrdU (1:300; GE healthcare). For DNA counterstaining we used
DAPI (Sigma). Secondary antibodies from Jackson ImmunoRe-
search were as follows: anti-guinea pig Alexa Fluor 488 (1:200),
anti-mouse Cy3 (1:500), and anti-mouse Alexa Fluor 647
(1:500). Immunofluorescence images were captured using a
Nikon confocal microscope. To assess β cell replication, at least
2000 β cells were counted per animal, and at least two slides at
a distance of >200 µm were analyzed.
Image analysis
All immunofluorescence images were captured on a Nikon C1
confocal microscope at a magnification of 40× randomly from at
least two different slices. The islets were identified by insulin la-
beling and captured throughout the entire slide. The number of
labeled cells was quantified using Fiji software. The numbers of
insulin-labeled cells bearing BrdU-labeled nuclei was normalized
to the total number of insulin-positive cells in islet, and expressed
in percentage. The numbers of insulin- and glucagon-labeled cells
were quantified on slices immunostained for these two hor-
mones. The proportion of β cells was expressed as the ratio be-
tween number of insulin-positive cells among overall insulin-
and glucagon-labeled cells.
Quantification and statistical analysis
The results are expressed asmeans ± SEM (standard error ofmean)
for the indicated number of donors (as given in the figure legends)
or illustrated as mean value of all experiments (for biolumines-
cence profiles). The statistical differencewas tested by a Student’s
t-test to compare the two groups. A nonpaired Student’s t-test
was used to compare group donors. A one-way ANOVA test fol-
lowed by a nonpaired Student’s t-test comparisons was used to
comparemultiple conditions. All statistical tests were conducted
with GraphPad Prism 8 software. Statistical significance was de-
fined at P <0.05 (∗), P<0.01 (∗∗), P <0.001 (∗∗∗), and P < 0.0001
(∗∗∗∗). To assess the circadian characteristics of proliferation a
JTK_Cycle fittingmethodwas used (Hughes et al. 2010). The pro-
file was considered as circadian if adjusted P-value were <0.05.
Data availability
The accession numbers for the deposited data in GEO are
GSE151338 and GSE152751.
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